Literature DB >> 28658743

Correlation of Prostate Gland Size and Uroflowmetry in Patients with Lower Urinary Tract Symptoms.

Deepak Sundaram1, Ponnusamy Kasirajan Sankaran2, Gunapriya Raghunath3, S Vijayalakshmi3, J Vijayakumar3, Maria Francis Yuvaraj4, Munnusamy Kumaresan4, Zareena Begum4.   

Abstract

INTRODUCTION: Benign Prostatic Hyperplasia (BPH) is a common entity among men over 40 years of age with significant disability. It is a condition that occurs when the enlarged prostate gland compresses the urethra leading to Bladder Outlet Obstruction (BOO). AIM: To correlate the size of the prostate gland and uroflowmetry parameters in patients with Lower Urinary Tract Symptoms (LUTS).
MATERIALS AND METHODS: One hundred and twenty randomly selected male patients, from the ages of 41 to 70 years, with LUTS, and underwent trans abdominal sonogram and uroflowmetry were included in the study. The samples were divided into three groups according to the age; Group 1: 41 to 50 years, Group 2: 51 to 60 years, Group 3: 61 to 70 years.
RESULTS: In Group 1 (41 to 50 years), there were totally 28 patients with LUTS, out of which seven patients had BPH, indicating that about 5% of patients with LUTS have BPH. In Group 2 (51-60 years) there were totally 31 patients with LUTS, out of which 10 patients had BPH, indicating that 8% of patients with LUTS have BPH. In Group 3 (61-70 years) there were totally 61 patients with LUTS, out of which 33 patients had BPH, indicating that 27% of patients with LUTS had BPH. The mean age of patients with LUTS was 60 years with mean prostate size of 45 cm3. Enlarged prostate gland was present in 41% of patients with mean Q max of 14 ml/sec and post voidal volume of 48 ml.
CONCLUSION: This study concludes that the LUTS in older patients are mostly due to BPH leading to BOO. Also, patients with BPH in early ages can lead to increased Post voidal Residual Volume (PVR) following uroflowmetry. Thus, screening male patients with LUTS, at 40 years and above, is an ideal way to detect prostatic problems at an early stage.

Entities:  

Keywords:  Benign prostatic hyperplasia; Benign prostatic hypertrophy; Bladder outlet obstruction

Year:  2017        PMID: 28658743      PMCID: PMC5483645          DOI: 10.7860/JCDR/2017/26651.9835

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  16 in total

1.  EAU Guidelines on benign prostatic hyperplasia (BPH).

Authors:  J J de la Rosette; G Alivizatos; S Madersbacher; M Perachino; D Thomas; F Desgrandchamps; M de Wildt
Journal:  Eur Urol       Date:  2001-09       Impact factor: 20.096

Review 2.  A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder.

Authors:  Christopher R Chapple; Claus G Roehrborn
Journal:  Eur Urol       Date:  2006-02-17       Impact factor: 20.096

3.  The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy.

Authors:  M Caine
Journal:  J Urol       Date:  1986-07       Impact factor: 7.450

4.  Prostatic carcinoma and benign prostatic hyperplasia: MR imaging with histopathologic correlation.

Authors:  T Kahn; K Bürrig; B Schmitz-Dräger; J S Lewin; G Fürst; U Mödder
Journal:  Radiology       Date:  1989-12       Impact factor: 11.105

5.  Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey.

Authors:  Varant Kupelian; John T Wei; Michael P O'Leary; John W Kusek; Heather J Litman; Carol L Link; John B McKinlay
Journal:  Arch Intern Med       Date:  2006-11-27

6.  The importance of prostatic measuring by transrectal ultrasound in surgical management of patients with clinically benign prostatic hyperplasia.

Authors:  Daimantas Milonas; Darius Trumbeckas; Petras Juska
Journal:  Medicina (Kaunas)       Date:  2003       Impact factor: 2.430

7.  Prevalence and characteristics of lower urinary tract symptoms in men aged > or = 80 years.

Authors:  J Kellogg Parsons; Jaclyn Bergstrom; Jonathan Silberstein; Elizabeth Barrett-Connor
Journal:  Urology       Date:  2008-06-12       Impact factor: 2.649

8.  Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure.

Authors:  S A Kaplan; A E Te; L B Pressler; C A Olsson
Journal:  J Urol       Date:  1995-11       Impact factor: 7.450

9.  A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate.

Authors:  J H Wasson; D J Reda; R C Bruskewitz; J Elinson; A M Keller; W G Henderson
Journal:  N Engl J Med       Date:  1995-01-12       Impact factor: 91.245

10.  Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors.

Authors:  J Kellogg Parsons
Journal:  Curr Bladder Dysfunct Rep       Date:  2010-09-07
View more
  2 in total

1.  Prevalence, risk factors and quality of life of Lower Urinary Tract Symptoms (LUTS) among men attending Primary Care slum clinics in Bangalore: A cross-sectional study.

Authors:  Priyesh Kant; Leeberk Raja Inbaraj; Nirupama Navamani Franklyn; Gift Norman
Journal:  J Family Med Prim Care       Date:  2021-07-02

2.  A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0.

Authors:  Beth Russell; Hans Garmo; Kerri Beckmann; Pär Stattin; Jan Adolfsson; Mieke Van Hemelrijck
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.